Nootropic Supplement

NOW Alpha GPC 300mg

• 58/100 science score
• $22 price

Overview

Effectiveness is moderate due to limited RCTs (5 for cognition, n=390) at higher doses (1200mg/day per Sagaro 2023 meta-analysis) than product's 300-600mg; suitable for athletic use (1 RCT, 600mg). Safety strong from trials but tempered by stroke association (JAMA Network Open 2021, aHR 1.43 in 12M cohort). Quality good via GMP but lacks elite third-party sport testing. Overall balanced nootropic at fair value.

Key strengths

• GMP-certified production (Intertek SSCI) with full label transparency
• Affordable at $0.40 per 300mg serving
• No proprietary blend; soy sourcing disclosed

Our analysis

NOW Alpha GPC 300mg offers moderate cognitive/athletic support at a sub-clinical dose for dementia (below 1200mg from 5 RCTs/meta-analysis), with good GMP quality but no sport certifications. Safety solid short-term; monitor CVD risk per stroke association study. Solid value for general nootropic use.

Frequently asked questions

Is NOW Alpha GPC 300mg worth buying?

NOW Alpha GPC 300mg has a Verify Influencers trust score of 58/100 based on ingredient quality, clinical evidence, and third-party testing.

What is the trust score for NOW Alpha GPC 300mg?

NOW Alpha GPC 300mg scored 58 out of 100 in our science-backed analysis, which evaluates ingredient dosages against clinical literature and manufacturing transparency.

Browse all scored products · How products are scored